Bluejay Diagnostics announces 1-for-4 reverse stock split effective November 3
BJDX•Bluejay Diagnostics will implement a 1-for-4 reverse stock split effective November 3, 2026, reducing outstanding common shares from approximately 4,468,051 to approximately 1,117,013.
1. Split details
The split takes effect at 12:01 a.m. Eastern Time on November 3, with split-adjusted trading on the Nasdaq Capital Market under the existing symbol BJDX. Shares issuable upon exercise of prefunded warrants will decrease from 222,581 to 55,645, and fractional shares will be paid in cash.
